Palvella Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$150.56

-3.76 (-2.44%)

As of Sep 20, 10:16 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 21 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -64.9% upside

Low Target $42.56

Average Target $52.81

High Target $76.13

Current Price $150.56

Current
$150.56

Target
$52.81

$42.56 $52.81 avg $76.13

Scenario Analysis

Bear Case

$42.56

-71.7%

Low target

Base Case

$52.81

-64.9%

Avg target

Bull Case

$76.13

+-49.4%

High target

Risk/Reward

0.7x

Unfavorable

Price in Context

52-Week High

$161.38

-6.7% from high

52-Week Low

$54.48

+176.4% from low

Target vs 52W High

$52.81

-67.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%